Usefulness of the ACTION ICU score to predict complications requiring critical care in Mexican patients with non-ST-segment elevation myocardial infarction

ACTION ICU评分在预测墨西哥非ST段抬高型心肌梗死患者需要重症监护的并发症方面的应用价值

阅读:1

Abstract

OBJECTIVE: The Acute Coronary Treatment and Intervention Outcomes Network Intensive Care Unit (ACTION ICU) score is a tool for assessing the risk of complications associated with non-ST-segment elevation myocardial infarction (NSTEMI) requiring intensive care unit (ICU) admission. The study aimed to describe the usefulness of the ACTION ICU score in Mexican patients with NSTEMI. METHODS: A single-center, retrospective, observational, and comparative study of patients with NSTEMI admitted between January 2017 and December 2023; patients with respiratory failure, cardiac arrest, shock, and arrhythmias requiring a pacemaker on admission were excluded from the study. Based on the collected data, the ACTION ICU score was applied to all patients. The cutoff score for ICU admission is 5, with a 9.3% risk of complications. During hospitalization, the composite primary outcome included cardiac arrest, shock, heart block requiring a pacemaker, respiratory failure, stroke, or death. The score's performance was determined by calculating the area under the curve (AUC). RESULTS: A total of 345 NSTEMI patients were included; 41 (14.2%) developed the primary outcome. The most common complications were shock (12.5%) and respiratory failure (8.1%). A score of 0 to 5 points was present in 187 patients (54.2%), 10 of whom (5.3%) developed the primary outcome. The score had an AUC of 0.77 [CI 0.64-0.97, p value 0.01]. CONCLUSIONS: The ACTION ICU score showed acceptable discriminative ability for identifying patients with NSTEMI who need ICU care, providing a valuable tool to predict complications and implement best practices in medical units with limited resources.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。